{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:29:36Z","timestamp":1760142576012,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.biopha.2014.08.003","type":"journal-article","created":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T17:29:17Z","timestamp":1408728557000},"page":"685-692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immunohistochemical differential diagnosis between urothelial carcinoma and prostate adenocarcinoma among Egyptian patients"],"prefix":"10.1016","volume":"68","author":[{"given":"Saber A.","family":"Sakr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshera M.","family":"Abdel-Wahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa G.","family":"El-Sahra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2014.08.003_bib0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/sonc.2001.21961","article-title":"Bladder cancer in Africa: update","volume":"28","author":"El-Mawla","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.biopha.2014.08.003_bib0205","series-title":"Drugs, Diseases and Procedures","article-title":"Bladder cancer","author":"Steinberg","year":"2012"},{"key":"10.1016\/j.biopha.2014.08.003_bib0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canep.2009.08.008","article-title":"Incidence analyses of bladder cancer in the Nile delta region of Egypt","volume":"3\u20134","author":"Fedewa","year":"2009","journal-title":"Cancer Epidemiol"},{"issue":"250","key":"10.1016\/j.biopha.2014.08.003_bib0020","article-title":"Muscle invasive bladder cancer in Upper Egypt: the shift in risk factors and tumor characterristics","volume":"8","author":"Zarzour","year":"2008","journal-title":"BMC cancer"},{"key":"10.1016\/j.biopha.2014.08.003_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics","volume":"55","author":"Parkin","year":"2005","journal-title":"Cancer J Clin"},{"issue":"1","key":"10.1016\/j.biopha.2014.08.003_bib0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0959-8049(01)00350-1","article-title":"Estimates of cancer incidence and mortality in Europe in 1995","volume":"38","author":"Bray","year":"2002","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2014.08.003_bib0035","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.1995.03520310046028","article-title":"The role of increasing detection in the rising incidence of prostate cancer","volume":"273","author":"Potosky","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biopha.2014.08.003_bib0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2008.864","article-title":"Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial","volume":"301","author":"Lippman","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.biopha.2014.08.003_bib0045","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/1940-6207.CAPR-08-0092","article-title":"Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach","volume":"1","author":"Redman","year":"2008","journal-title":"Cancer Prev Res"},{"issue":"3","key":"10.1016\/j.biopha.2014.08.003_bib0050","first-page":"461","article-title":"E-cadherin and p63 immunoexpression in dysplastic lesions and urothelial carcinomas of the bladder","volume":"50","author":"Stepan","year":"2009","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.biopha.2014.08.003_bib0055","first-page":"6","article-title":"Diagnostic utility of p63\/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma","author":"Srinivasan","year":"2011","journal-title":"Diagn Pathol"},{"issue":"2","key":"10.1016\/j.biopha.2014.08.003_bib0060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1158\/1055-9965.EPI-08-0785","article-title":"Aberrant cytoplasmic expression of p63 and prostate cancer mortality","volume":"18","author":"Dhillon","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"key":"10.1016\/j.biopha.2014.08.003_bib0065","first-page":"360","article-title":"Keratin expression in human tissues and neoplasms","volume":"41","author":"Chu","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.biopha.2014.08.003_bib0070","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0210-4806(06)73513-6","article-title":"Immunohistochemical profile and clinical features of mucinous tubular and spindle renal cell carcinoma","volume":"30","author":"Arias","year":"2006","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.biopha.2014.08.003_bib0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF00054016","article-title":"Role of intermediate filaments in migration, invasion, and metastasis","volume":"15","author":"Hendrix","year":"1996","journal-title":"Cancer Metastasis Rev"},{"issue":"10","key":"10.1016\/j.biopha.2014.08.003_bib0080","first-page":"1329","article-title":"Cytokeratin 7, Clone: OV-TL 12\/30","volume":"30","author":"Hatta","year":"2004","journal-title":"Dermatol Surg"},{"issue":"7","key":"10.1016\/j.biopha.2014.08.003_bib0085","doi-asserted-by":"crossref","first-page":"921","DOI":"10.5858\/2001-125-0921-CACIPU","article-title":"Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis","volume":"125","author":"Jiang","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.biopha.2014.08.003_bib0090","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2958.2009.06796.x","article-title":"The Streptococcus pneumoniae adhesin PsrP binds to keratin 10 on lung cells","volume":"73","author":"Shivshankar","year":"2009","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.biopha.2014.08.003_bib0095","series-title":"Diagnostic Immunohistochemistry","first-page":"407","article-title":"Immunohistochemistry of the prostate and bladder, testis, and renal tumors","author":"Bostwick","year":"2002"},{"key":"10.1016\/j.biopha.2014.08.003_bib0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1746-1596-2-41","article-title":"Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma","volume":"2","author":"Yin","year":"2007","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.biopha.2014.08.003_bib0105","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1309\/DT6BJ698LDX2NGGX","article-title":"Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel","volume":"125","author":"Nitadori","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.biopha.2014.08.003_bib0110","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3748\/wjg.v9.i10.2202","article-title":"Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma","volume":"9","author":"Zhao","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.biopha.2014.08.003_bib0115","series-title":"Cancer pathology registeration 2003\u20132004 and time trend analysis.","first-page":"32","article-title":"Malignant urinary system tumors","author":"Mokhtar","year":"2004"},{"key":"10.1016\/j.biopha.2014.08.003_bib0120","series-title":"Topographic pathology of cancer","first-page":"65","article-title":"Prostate cancer","author":"El-Bolkany","year":"2005"},{"issue":"1","key":"10.1016\/j.biopha.2014.08.003_bib0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0377-4929.77326","article-title":"Utility of p63 immunohistochemical stain in differentiating urothelial carcinomas from adenocarcinomas of prostate","volume":"54","author":"Din","year":"2011","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.biopha.2014.08.003_bib0130","series-title":"Robbins and Cotran Pathologic Bases of Diease","first-page":"1024","article-title":"Disease of the prostate","author":"Epstein","year":"2005"},{"key":"10.1016\/j.biopha.2014.08.003_bib0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0090-4295(00)00952-3","article-title":"New concepts in the pathology of prostatic epithelial carcinogens: a review of the molecular changes in prostate cancer","volume":"57","author":"De Marzo","year":"2001","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.biopha.2014.08.003_bib0140","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1097\/01.ju.0000140958.31366.9f","article-title":"Prostate cancer characteristics and prostate specific antigen changes in screening detected patients initially treated with a watchful waiting policy","volume":"172","author":"De Vries","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.biopha.2014.08.003_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2559.2005.02188.x","article-title":"Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature","volume":"47","author":"Varma","year":"2005","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.biopha.2014.08.003_bib0150","first-page":"4850","article-title":"Urothelial carcinoma and prostatic adenocarcinoma presenting as collision tumors","volume":"16","author":"Mai","year":"2009","journal-title":"Can J Urol"},{"issue":"5","key":"10.1016\/j.biopha.2014.08.003_bib0155","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1309\/V1RY91NKX5ARW2Q5","article-title":"Prostate specific antigen, high molecular weight cytokeratin (clone 34betaE12), and\/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma","volume":"125","author":"Kunju","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.biopha.2014.08.003_bib0160","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.humpath.2010.12.024","article-title":"Flat urothelial carcinoma in situ of the bladder with glandular differentiation","volume":"42","author":"Lopez-Beltran","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.biopha.2014.08.003_bib0165","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1309\/G1RA-EU9X-X6VV-3W79","article-title":"Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma","volume":"113","author":"Bassily","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.biopha.2014.08.003_bib0170","first-page":"6","article-title":"Cytokeratin 8\/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity","author":"Fillies","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2014.08.003_bib0175","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1053\/hupa.2001.26466","article-title":"Keratin 1 expression in endothelia and mesenchymal tumors: an immunohistochemical analysis of normal and neoplastic tissues","volume":"32","author":"Remotti","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.biopha.2014.08.003_bib0180","first-page":"220","article-title":"Clinic significance of morphometric study on squamous cell carcinoma of floor of mouth","volume":"22","author":"Zhao","year":"2004","journal-title":"Hua Xi Kou Qiang Yi Xue Za Zhi"},{"issue":"23","key":"10.1016\/j.biopha.2014.08.003_bib0185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00000478-199902000-00002","article-title":"Rare expression of high molecular weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer","volume":"2","author":"Yang","year":"1999","journal-title":"Am J Surgical Pathol"},{"issue":"9","key":"10.1016\/j.biopha.2014.08.003_bib0190","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/PAS.0b013e31802ff7c4","article-title":"Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases","volume":"31","author":"Osunkoya","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.biopha.2014.08.003_bib0195","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/PAS.0b013e3181656ca0","article-title":"Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder","volume":"32","author":"Lane","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.biopha.2014.08.003_bib0200","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1309\/V1RY91NKX5ARW2Q5","article-title":"Prostate specific antigen, high molecular weight cytokeratin (clone 34\u03b2 \u03b2E12), and\/or p63 an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma","volume":"125","author":"Lakshmi","year":"2006","journal-title":"Am J Clinical Pathol"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332214000973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332214000973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:53:58Z","timestamp":1760093638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332214000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0753332214000973"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2014.08.003","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemical differential diagnosis between urothelial carcinoma and prostate adenocarcinoma among Egyptian patients","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2014.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}